Tobacco reduction in a prison of France

被引:2
作者
Harcouet, L. [1 ]
Balanger, S. [2 ]
Meunier, N. [2 ]
Mourgues, A. [1 ]
Grabar, S. [3 ]
Haouili, B. [2 ]
Guillevin, L. [2 ]
机构
[1] Univ Paris 05, Hop Cochin, AP HP, Serv Pharm, F-75014 Paris, France
[2] Univ Paris 05, Hop Cochin, AP HP, Serv Med Interne, F-75014 Paris, France
[3] Univ Paris 05, Hop Cochin, AP HP, Serv Informat Med, F-75014 Paris, France
来源
REVUE DE MEDECINE INTERNE | 2008年 / 29卷 / 05期
关键词
prisons; behaviour addictive; tobacco use cessation; nicotine replacement therapy;
D O I
10.1016/j.revmed.2007.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subject - Little is known about free nicotine transdermal patch efficacy on tobacco reduction in prisoners. The objective is to study this efficacy in prison as well as motivations to reduce and influence of socioeconomic conditions and other addictions in prisoners' aspiration to stop smoking. Methods. - A prospective study was proposed to prisoners candidate to tobacco cessation. Assessment was made by questionnaires and visits to physicians working at the prison. Nicotinic patches were systematically proposed to patients with a starting 15 mg/16 h dose (or 10 mg/1 6 h if the dependence was low), followed by a 10 and 5 mg/16 h dose reduction. Results. - Prisoners motivated to smoking cessation (N= 73) generally had multiaddictive behaviours and precarious socioeconomic profile. Thirty percent of prisoners self-reported a reduction of 50% of their cigarettes consumption until they left prison. Median duration of this successful treatment was 45 days. Median duration of treatment response for patients who relapsed in prison (15 %) was 75 days. No predictive factor of success was found. Conclusion. - Tobacco reduction is possible in prison even if living conditions are not favourable. (C) 2007 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 36 条
  • [1] [Anonymous], BEH
  • [2] *ARR CONS TUB, 1998, C CONS ANAES 8 9 OCT
  • [3] BECK F, 2004, REGARDS ACTUALITE, V298, P77
  • [4] Smoking and its correlates in an Australian prisoner population
    Belcher, Josephine M.
    Butler, Tony
    Richmond, Robyn L.
    Wodak, Alex D.
    Wilhelm, Kay
    [J]. DRUG AND ALCOHOL REVIEW, 2006, 25 (04) : 343 - 348
  • [5] The association between depressive symptoms and cigarette smoking in an urban primary care sample
    Brown, C
    Madden, PAF
    Palenchar, DR
    Cooper-Patrick, L
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2000, 30 (01) : 15 - 26
  • [6] *CFES, 2000, BAR SANT, V2
  • [7] DOUBLE-BLIND TRIAL OF REPEATED TREATMENT WITH TRANSDERMAL NICOTINE FOR RELAPSED SMOKERS
    GOURLAY, SG
    FORBES, A
    MARRINER, T
    PETHICA, D
    MCNEIL, JJ
    [J]. BRITISH MEDICAL JOURNAL, 1995, 311 (7001) : 363 - 366
  • [8] GREMY I, 2004, BEH, V22, P90
  • [9] Guerin G., 2003, ACTUALITE DOSSIER SA, V44, P21
  • [10] Harcouet L., 2000, Journal de Pharmacie Clinique, V19, P149